STOCK TITAN

Immuron (IMRN) 424B Filings

IMRN NASDAQ

Here are the 424B prospectus supplements from Immuron Limited (IMRN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow IMRN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IMRN filings page.

Rhea-AI Summary

Immuron Ltd. (IMRN) amended its at-the-market offering to permit the offer and sale of up to approximately $2,006,769 in aggregate offering price of American Depositary Shares (ADSs) representing ordinary shares. Sales, if any, may be made from time to time through H.C. Wainwright & Co., LLC, acting as sales agent or principal. The supplement reduces the prior maximum aggregate offering price to this amount.

Under Form F-3’s one-third public-float limit, Immuron states that it had sold approximately $2,847,703 in securities during the 12 calendar months through October 23, 2026, leaving eligibility to offer up to an additional $2,006,769. The one-third limit was $4,854,473 as of October 23, 2026, and applies while public float remains below $75 million. Immuron will pay Wainwright a cash commission equal to 3.0% of gross sales price; Wainwright is not required to sell any specific number or dollar amount.